Maraviroc
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1389 publications
Cellular context and ligand class shape CXCR4-CCR5 heteromerization in live cells.
Journal: Research square
Published: June 04, 2026
Efficacy and Safety of Different GVHD Prophylaxis Regimens for Unrelated Donor Hematopoietic Stem Cell Transplantation: A Real-World Long-Term Retrospective Study
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 02, 2026
CCR5 and CD74 are potential therapeutic targets for necroinflammation in preclinical cholesterol crystal embolism.
Journal: Science translational medicine
Published: May 27, 2026
C-C motif chemokine 3 interferes with oligodendrocyte maturation in the brain.
Journal: Biochemical and biophysical research communications
Published: March 07, 2026
Physiologically Based Pharmacokinetic Modeling to Assess Antiretroviral-BTK Inhibitor Interactions and Provide Recommendations for Co-Administration Regimens.
Journal: Pharmaceutics
Published: March 02, 2026
Virtual screening and molecular fingerprinting for in silico designing of potential CCR5 inhibitors targeting HIV therapy.
Journal: Journal of biomolecular structure & dynamics
Published: March 01, 2026
Maraviroc ameliorates doxorubicin-induced atrioventricular block through blocking CCL5-CCR5 interaction in macrophage-cardiomyocyte axis.
Journal: European journal of pharmacology
Published: February 18, 2026
Effectiveness of interventions on cognitive decline risk for people living with HIV on antiretroviral therapy: a systematic review.
Journal: The lancet. Healthy longevity
Published: December 23, 2025
Last Updated: 06/30/2026